Inflammation
Mechanism is strong (CB2 receptors), but almost all the evidence is laboratory and animal — human trials lag far behind.
Other Emerging
What the research says
At the lab-bench level, the anti-inflammatory story is one of the most consistent in cannabis science. CB2 receptor activation (which CBD and especially beta-caryophyllene trigger) reduces inflammatory signaling across dozens of animal models — colitis, arthritis, neuroinflammation, autoimmune disease.
The gap: translating that into 'this helps my inflammation' in a human is not a given. Human trials are sparse, use variable products, and inflammation is measured inconsistently across studies. The mechanism is real; the human proof is pending.
Recent peer-reviewed work has broadened the roster well beyond CB2. CBGA was the most potent blocker of store-operated calcium entry among 22 cannabinoids screened — a pathway that drives T-cell activation and inflammatory cytokine release — and CBDV reduces IL-6 and TNF-α production in immune cells. Among terpenes, guaiol shifts macrophages toward the anti-inflammatory M2 phenotype through PPAR-γ signaling, and isopulegol, valencene, 3-carene, citronellol, and alpha-terpineol each show anti-inflammatory activity in mouse or cell models. All of it is preclinical: it builds the case for human trials, it doesn't prove a strain treats a specific inflammatory condition.
The honest caveats
This is the difference between 'this compound is anti-inflammatory in cells' and 'this strain treats my condition.' For autoimmune diseases specifically, never stop or reduce prescribed immunosuppressants based on cannabis — the stakes are too high. If you're curious, CBD or caryophyllene-forward products are the reasonable experiments, and your doctor should know you're taking them.
Compounds to explore
These are the compounds — terpenes and cannabinoids — that the research connects to this condition. They are starting points for reading a COA or choosing a product, not prescriptions. Each has its own guide with more detail.
Terpene beta-caryophyllene A dietary terpene that directly activates CB2 receptors — the anti-inflammatory pathway. Cannabinoid CBD Consistently anti-inflammatory in lab and animal models. Terpene humulene Anti-inflammatory in early research; also in hops. Cannabinoid CBGA The most potent blocker of store-operated calcium entry among 22 cannabinoids screened — a key driver of inflammatory cytokine release. Cannabinoid CBDV Reduced IL-6 and TNF-α production in immune cells — a measurable anti-inflammatory lab effect. Cannabinoid CBL The first in vivo study found it reduced inflammation in mice, apparently through adenosine A2A receptors — at high doses. Cannabinoid CBNA Ranked among the five most potent acidic cannabinoids at blocking the immune-cell pathway behind inflammatory signaling. Terpene guaiol A 2024 study found it shifts macrophages toward the anti-inflammatory M2 phenotype via PPAR-γ signaling. Terpene isopulegol Reduced paw edema and inflammatory markers in mice. Terpene valencene Reduced ear edema in mice, with molecular docking pointing to anti-inflammatory targets. Terpene 3-carene Anti-inflammatory activity in both in vitro and in vivo models. Terpene citronellol A systematic review catalogs consistent anti-inflammatory findings across animal and lab models. Terpene alpha-terpineol A broad review of its pharmacology documents anti-inflammatory activity across dozens of studies. Terpene alpha-pinene Anti-inflammatory, antioxidant, and bronchodilating activity in lab research. Terpene beta-pinene Shares alpha-pinene's anti-inflammatory and antimicrobial activity, though the research is thinner. Terpene caryophyllene oxide Anti-inflammatory potential flagged in the entourage literature; the oxidation byproduct of caryophyllene. Cannabinoid THCA Anti-inflammatory and neuroprotective in early research; the raw, non-intoxicating precursor to THC. Cannabinoid CBG Strong CB2-mediated anti-inflammatory and immunoregulatory effects shown in early research. Cannabinoid CBC A CB2 compound that may down-regulate inflammatory responses where the immune system overreacts. Terpene ocimene Early research points to anti-inflammatory and antimicrobial potential. Terpene geraniol Among the better-studied minor terpenes; anti-inflammatory and antioxidant in lab and animal models. Terpene bisabolol Best documented for anti-inflammatory and skin-soothing properties. Terpene farnesene Carries anti-inflammatory and antioxidant activity in early research. Terpene trans-beta-farnesene The common farnesene isomer — the same early anti-inflammatory and antioxidant signal. Terpene trans-beta-farnesol The farnesol family has shown anti-inflammatory activity in lab models. Terpene trans-ocimene The common ocimene form; early evidence of anti-inflammatory activity. Terpene nerol Shares geraniol's antimicrobial and anti-inflammatory activity. Terpene alpha-terpinene Carries the antioxidant and antimicrobial activity shared across the terpinene family. Terpene gamma-terpinene Shares the family's antimicrobial and anti-inflammatory activity, with a standout antioxidant effect. Terpene fenchol Antibacterial and anti-inflammatory activity highlighted in research. Terpene sabinene Shows anti-inflammatory and antimicrobial potential in research.Sources for this condition
- https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.908198/full
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9334010/
- https://www.mdpi.com/1422-0067/24/3/2721
- https://pubmed.ncbi.nlm.nih.gov/41478536/
- https://link.springer.com/article/10.1186/s42238-025-00384-7
- https://pmc.ncbi.nlm.nih.gov/articles/PMC12801675/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7278878/
- https://www.em-consulte.com/article/1538672
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6308289/
- https://pubmed.ncbi.nlm.nih.gov/30453001/
- https://www.degruyterbrill.com/document/doi/10.1515/chem-2018-0040/html